Shadman, M., Brown, J. R., Mohseninejad, L., Yang, K., Burnett, H., Neupane, B., . . . Tam, C. S. Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: A network meta-analysis. Elsevier.
Chicago Style (17th ed.) CitationShadman, Mazyar, et al. Comparative Efficacy of Bruton Tyrosine Kinase Inhibitors in High-risk Relapsed/refractory CLL: A Network Meta-analysis. Elsevier.
MLA (9th ed.) CitationShadman, Mazyar, et al. Comparative Efficacy of Bruton Tyrosine Kinase Inhibitors in High-risk Relapsed/refractory CLL: A Network Meta-analysis. Elsevier.
Warning: These citations may not always be 100% accurate.